A CRISPRi/a screening platform to study cellular nutrient transport in diverse microenvironments

Christopher Chidley1, Alicia M Darnell2, Benjamin L Gaudio3

  • 1Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, USA. christopher_chidley@hms.harvard.edu.

Nature Cell Biology
|April 11, 2024
PubMed

Insights

Targeting nutrient transporters is key for cancer therapy. This study developed a screening platform to identify essential transporters in leukemia and tumors, revealing microenvironment-dependent nutrient flux and novel roles in preventing cell death.

Area of Science:

  • Cancer Biology
  • Molecular Biology
  • Metabolic Pathways

Background:

  • Targeting nutrient import is a promising cancer therapy strategy.
  • Identifying specific nutrient transporters crucial for cancer cell survival and proliferation is challenging.
  • The tumor microenvironment significantly influences cancer cell metabolism and transporter function.

Purpose of the Study:

  • To develop and apply a CRISPR screening platform for systematically identifying essential nutrient transporters in cancer.
  • To characterize the role of amino acid transporters in leukemia cells and their dependence on microenvironment.
  • To uncover novel nutrient transporter functions, including those involved in ferroptosis and tumor growth.

Main Methods:

  • CRISPR interference/activation screening platform to interrogate nutrient transporter function.
  • Application of the platform to leukemia cells and subcutaneous tumor models.
  • Analysis of nutrient flux, cell proliferation, and ferroptosis under varying environmental conditions.

Main Results:

  • Identified critical amino acid transporters in leukemia, demonstrating high bidirectional flux influenced by microenvironment.
  • Discovered a role for serotonin uptake in preventing ferroptosis in cystine-starved cells.
  • Found that glucose and amino acid availability can limit proliferation in subcutaneous tumors, identifying essential transporters for tumor growth.

Conclusions:

  • Established a robust framework for systematic identification and functional characterization of cellular nutrient transporters.
  • Highlighted the dynamic and microenvironment-dependent nature of nutrient transport in cancer.
  • Provided insights into novel therapeutic targets and strategies for modulating cancer metabolism.

Related Concept Videos

CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...